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Abstract
Health-enhancing potential bioactive peptide (BP) has driven an interest in food proteins as
well as in the development of predictive methods. Research in this area has been especially
active to use them as components in functional foods. Apparently, BPs do not have a given
biological function in the containing proteins and they do not evolve under independent evo-
lutionary constraints. In this work we performed a large-scale mapping of BPs in sequence
and structural space. Using well curated BP deposited in BIOPEP database, we searched
for exact matches in non-redundant sequences databases. Proteins containing BPs, were
used in fold-recognition methods to predict the corresponding folds and BPs occurrences
were mapped. We found that fold distribution of BP occurrences possibly reflects sequence
relative abundance in databases. However, we also found that proteins with 5 or more than
5 BP in their sequences correspond to well populated protein folds, called superfolds. Also,
we found that in well populated superfamilies, BPs tend to adopt similar locations in the pro-
tein fold, suggesting the existence of hotspots. We think that our results could contribute to
the development of new bioinformatics pipeline to improve BP detection.
Introduction
As several endocrine and nervous systems in mammals are regulated by endogenous peptides,
many of them could also be regulated by exogenous peptides performing hormone-like func-
tions [1]. Due to their physiological importance and regarding their nutritional values, these
peptides are called bioactive peptides or just biopeptides (BP) [2]. In the last years, several
works from food science and biotechnological areas have shown that several food proteins
contain different amounts of these exogenous peptides [3,4]. In general, these peptides are
between 3 and 20 amino acids long and are found as encrypted regions in protein sequences.
During the gastrointestinal digestion, these peptides are released from proteins by the action
of digestive enzymes and could be absorbed through the intestine to enter the blood circula-
tion. The pathway and the absorption mechanism differ according the length and charge of
the peptide. In intestinal light di and tripeptides are uptake into the enterocyte through the
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intestinal endothelium by the co-transporter PepT1[5]. There is also evidence that some di
and tripeptides can survive cytosolic hydrolysis and be transported intact through the basolat-
eral membrane [6]. Other peptides can (although in a much smaller proportion) diffuse
through tight junctions and / or enter through vesiculation [7]. Releasing process could also be
reproduced in vitro conditions which allow their purification and biochemical characterization
[8,9]. Once in blood circulation, BP can modulate the biological activity of several human
enzymes playing key roles in different metabolisms such as the regulation of blood pressure,
stimulating or suppressing the action of the immune system, modulating the activity of the
nervous system, showing an anti-inflammatory effect and inducing a reduction in cholestero-
laemia among others [10]. It has been found that biological effects of BP mostly reside on their
sequence or primary information, but could also be related with composition [11,12] and with
their spatial arrangements [13,14]. In general they exert just one biological activity but it has
been described that some could have multifunctional activities [15].
Due to their health-enhancing potential, BP research has been especially active to use them
as components in functional foods or nutraceuticals [3,16,17]. A functional food is a natural o
processed food which contains a biologically-active compounds, which in defined amount
benefits a limited number of functions in the body providing welfare and health benefit for the
prevention, management, or treatment of chronic disease [18]. In this sense, several databases
and bioinformatics tools have been developed to predict and study BP occurrence in food pro-
teins. Among the databases, we found PepBank [19], Antimicrobial Peptide Database (APD)
[20] and BIOPEP [21]. Databases are the main source of information to predict occurrence of
BP in proteins. Basically, primary structure information of characterized peptides is used to
search for sequence similarity to predict occurrence of BP in different proteins. Sequence simi-
larity searches are commonly performed using BLAST and PSI-BLAST programs [22]. Also,
primary structure could be also used to train machine learning algorithms to predict occur-
rence of BP [23] and also for simulation of BP release by the action of digestive enzymes in a
digestive in silico simulation process [24]. Sequence similarity searches between BP and target
sequences then are the major methodologies to estimate the presence of BP. This is inherently
connected with the nature of BP in the containing proteins. Apparently, the BP encoded in
food proteins does not have a given biological function in those proteins and for that reason
do not evolve under given evolutionary constraints (i.e. to preserve structure, function, stabil-
ity). This fact reveals the main difficulties observe to predict occurrence of BP in proteins since
most bioinformatics tools take advantage of differential patterns of amino acid substitution
(i.e. conservation or coevolution) to discover and predict special important regions in
proteins.
In this work we perform a large-scale characterization of BP in sequence and structural
space. We search for exact occurrences of BP in non-redundant database. We retrieved all the
protein sequences containing at least one occurrence of BP which was then submitted to a fold
assignment pipeline using CATH database [25]. With those sequences with a detected struc-
tural template, we mapped BP positions on the structure representing all the members of each
homologous superfamily detected in this study. Two main results emerged from our study.
We found that some superfamilies show co-localization of several BP in their structures show-
ing same or different biological activity. Also we found that proteins with more than 5 BPs in
their sequences belongs to superfamilies with great structural and sequence variability as
derived from CATH superfamilies analysis. Both results could help in the design of bioinfor-
matic tools to localize given BPs and given structural superfamilies and also to select proteins
having larger probabilities to contain BP in food protein screening.
Mapping bioactive peptides in proteins fold
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Materials and methods
Using BIOPEP database (http://www.uwm.edu.pl/biochemia/index.php/pl/biopep) [21] of
bioactive peptides, we have selected each peptide above 5 residues long to perform a BLAST
sequence search in nr database. From these results, we selected those sequence having exact
matches for all the residues in each peptide. To reduce redundancy of the obtained sequences
we used CD-Hit program (http://weizhongli-lab.org/cd-hit/) [26] at 100% cut-off to eliminate
all duplicated sequences. We then performed a fold assignment for each of the sequence. For
this purpose, we used BLAST searches (BLASTP) using default parameters against CATH
database (http://www.cathdb.info/) [27]. For each sequence we selected best CATH domains
matches (each with a E-value below 1x10-3) corresponding to non-overlapping segments of
each sequence to assign a CATH domain in the case the protein have more than two structural
domains. We also searched among the results for those segments having a peptide to assign a
CATH domain. For each CATH domain identified in our dataset, we have used the informa-
tion derived for the Funtree database [28] as well as CATH specific annotation (http://www.
cathdb.info/) to studied GO terms annotations.
For those sequences where was possible to assign a given fold, we then proceed to perform
a structural mapping of the peptides on putative templates. For this purpose, we performed a
two steps procedure (Fig 1). First, we aligned each sequence with its corresponding putative
template, indicated by the CATH domain ID, using ClustalX [29]. We then structurally aligned
the CATH domain (template) with the protein fold which is taken as representative of corre-
sponding structural superfamily, following CATH, using the program ProFit (http://www.
bioinf.org.uk/programs/profit/index.html). In CATH database structural superfamilies have
the same first four CATH number (Class, Architecture, Topology and Homologous numbers
characterize a given structural superfamily). Each superfamily could have several homologous
Fig 1. Diagram of structural mapping of the bioactive peptides on structural superfamilies. Once a BP was
detected in a given protein after sequence exact searches, we identified putative folds for that sequence using fold-
assignment techniques. Templates in this fold identification were those domains deposited in CATH database. We
then structurally aligned the sequence putative CATH template with the corresponding representative protein of the
structural superfamily again accordingly with CATH database. We finally mapped the BP occurrence to the
representative template of each structural superfamily.
https://doi.org/10.1371/journal.pone.0191063.g001
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families characterized by the fifth; sixth and so on CATH id numbers indicating levels of
sequence conservation (for example, S35 represent the number of homologous families shar-
ing more than 35% identity between the corresponding members). With this procedure, we
were able to map peptides in a unique protein fold representing different proteins for the same
homologous family. Each protein fold with all the mapped peptides were identify with the four
first numbers corresponding to CATH database. In addition, we used CATH derived informa-
tion to characterize the structural superfamily divergence using the number of structural clus-
ters and the number of S35 homologous families in each structural superfamily.
Results and discussion
Mapping biopeptides in sequence and structural space
To assess how structural information could be used in the identification of bioactive peptides,
we performed a large-scale database sequence search followed by a structural mapping. Using
BLAST searches against non-redundant database, we searched for proteins containing exact
matches for each peptide more than 5 residues long taken from BIOPEP database [21]. Using
2595 peptides as input for similarity searches, we retrieved 88909 protein sequences with at
least one occurrence of a given BP. We used the program CD-HIT [26] to reduce the redun-
dancy of the set removing 100% identity sequences, remaining 80523 unique sequences. We
then performed a fold assignment for each of these sequences using BLAST searches against
sequences corresponding to structural domains contained in CATH database. CATH database
is a structural database of all known protein structures chopped as structural domains. CATH
classified each domain with a series of numbers to identify its structural class (C), architecture
(A), topology (T) and homologous superfamily (H). As proteins in our dataset could contain
multiple structural domains, we only assigned a putative template for those containing pep-
tides. From BLAST searches against CATH domains, we selected those containing E-values
less than 1x10-3. Using this method, we were able to assign a putative template to 58167
sequences (72.2%). Sequences and putative templates were then aligned using ClustalX [29]. In
order to map the occurrence of peptides in the corresponding protein fold, we structurally
aligned templates with the representative protein fold corresponding to the homologous
superfamily taken from CATH. Using this multiple alignment between a sequence containing
the exact match of a given bioactive peptide, its corresponding putative template, and the rep-
resentative protein fold for the corresponding structural family; we proceeded to map the loca-
tion of the bioactive peptide on the representative fold. This procedure was followed for each
protein in our dataset. A flowchart of all these procedure is shown in Fig 2.
Using CATH domain classification, we found that all sequences clustered in 333 domain
superfamilies. In Fig 3 and Table 1 we show the obtained distribution of proteins folds.
It is interesting to note that four main folds accounts for the 87.54% of the sequences. The
most populated cluster with 33.6% of the sequences corresponds to the fold with CATH id
3.30.70.150, an alpha-beta 2-layers sandwich. This fold is represented by ribulose bisphosphate
carboxylase large chain (RuBisCO large subunit) (EC 4.1.1.39) and most proteins are close
homologous to RuBisCO. A minor percentage of the proteins are represented by a relative of
RuBisCO, the 2,3-diketo-5-methylthiopentyl-1-phosphate enolase (DK-MTP-1-P enolase)
(EC 5.3.2.5) the so-called RuBisCO-like protein. Almost 96% of the proteins in this cluster
belong to plants and the rest to Bacteria, mainly Cyanobacterias. This cluster is followed in
abundance by a mainly alpha, orthogonal bundle (CATH id 1.10.287.210) which accounts for
the 27.5% of the sequences. The 92.8% of these sequences in this cluster belongs to Viruses and
are represented by the protein Envelope glycoprotein gp160 (Envpolyprotein). A mainly beta
fold with a complex beta structure (CATH id 2.170.40.20) accounts for the 21.3% of sequences.
Mapping bioactive peptides in proteins fold
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These proteins belong to the so-called Envelope glycoprotein gp160 (Envpolyprotein).
Finally, the family representing the Actin (beta-actin) and actin-related proteins (CATH id
3.30.420.40) accounts for the 5.14% of the sequences in the dataset. In Table 1 we show the top
10 protein superfamilies structurally clustering the sequences used in this study. It is evident
that these distributions do not reflect any particular property of folds containing BP (differen-
tial stability, special structure-function relationship, etc.), but just the sequence distribution in
the database derived from genome sequence projects. From these most populated folds, the
Actin fold (CATH id 3.30.420.40) is the only belonging to the class denominated “superfold”
Fig 2. Flowchart of main procedure followed to mapping the structural occurrence of biopeptides.
https://doi.org/10.1371/journal.pone.0191063.g002
Fig 3. Distribution of protein folds that contains biopeptides extracted from BIOPEP database.
https://doi.org/10.1371/journal.pone.0191063.g003
Mapping bioactive peptides in proteins fold
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[30], which are those folds associated to a large number of families and functions. We will see
below the importance of superfolds in BP biology.
Mapped biopeptides and structural superfamilies
The distribution of mapped biopeptides on protein folds changes when we considered the
number of different biopeptides associated to each structural domain. The structural families
CATH id 3.30.70.150, 3.30.420.40 and 1.10.287.210 mentioned above, are only associated with
just one biopeptide but the family 3.30.420.40 with 7 different biopeptides.
When we studied the occurrence of different biopeptides in a given structural domain, we
found that a given protein fold could contain several biopeptides with the same or different
associated functions. In S2 Table we show the number of biopeptides associated with a given
protein fold, showing only the top containing proteins. It is then possible to observe that the
fold with CATH ID 3.40.50.300 (P-loop containing nucleotide triphosphate hydrolases super-
family) contains 35 different biopeptides showing 12 different biological activities being the
maximum number of different peptides mapped in a given fold. This distribution falls to 197
different folds just containing the occurrence of only 1 BP.
When we studied GO terms annotations [31] of each CATH domain as a function of the
number of mapped biopeptides per structural domain, we found that proteins associated with
larger number of biopeptides are functionally more diverse. In Fig 4 we show the distribution
of GO terms associated with folds with more and less than 5 biopeptides. Using the three types
of GO terms (molecular function, biological process and cellular components) folds with more
than 5 biopeptides appear functionally more diverse than those sequences with fewer occur-
rences of BP (Fig 4a, 4b and 4c). We obtained a similar result using the functional clusters
derived in Funtree [28] which is also associated with CATH database. In Fig 3d, we show the
distribution for the number of different functional clusters which again show more functional
diversification for those proteins associated with more than 5 biopeptides. Interestingly, the
Table 1. Description of the top ten most abundant superfamilies found in the assignation of structure of the sequences with at least one peptide.
Percentage of proteins
with assigned fold
CATH Representative domain
in CATH
C A T Representative protein
33.60 3.30.70.150 1wddA01 Alpha
Beta
2-Layer sandwich Alpha-Beta plaits Large subunit rubisco
27.47 1.10.287.210 1qbzA00 Mainly
Alpha
Orthogonal
bundle
Helix hairpins Envelope glycoprotein gp160
21.30 2.170.40.20 1kmoA02 Mainly
Beta
Beta barrel Maltoporin; chain A HIV envelope protein
Gp120; chain G
5.14 3.30.420.40 3i33A01 Alpha
Beta
2-Layer
Sandwich
Nucleotidyl transferase;
domain 5
Plasmodium falciparum
actin I
1.52 1.10.490.10 2nrlA00 Mainly
Alpha
Orthogonal
Bundle
Globin-like Blackfin tuna myoglobin
1.67 2.30.36.70 1s22A02 Mainly
Beta
Roll Actin; chain A, domain 2 Actin; chain A, domain 3
0.55 3.40.190.10 1ixhA01 Alpha
Beta
3-Layer(aba)
Sandwich
D-maltodextrin binding
protein; domain 2
Periplasmic binding protein-
like II
0.54 2.60.40.720 2ioiA00 Mainly
Beta
Sandwich Immunoglobulin-like Human mutant, p53
0.53 3.40.50.720 1c0pA01 Alpha
Beta
3-Layer(aba)
Sandwich
Rossmann fold NAD(P)-binding
Rossmann-like domain
0.42 2.60.120.10 1juhA02 Mainly
Beta
Sandwich Jelly rolls Jelly rolls
https://doi.org/10.1371/journal.pone.0191063.t001
Mapping bioactive peptides in proteins fold
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distribution of sequences lengths for the proteins with more and less than 5 BP is statistically
different (Two-sample Kolmogorov-Smirnov test p-value < 0.001) but unexpectedly proteins
with more BP are shorter.
When we studied the relationship of sequence divergence to structural conservation we
found that proteins associated to more than 5 biopeptides per fold have higher number of
sequences per protein fold but also a larger number of structural clusters (Fig 5). Both mea-
sures are indicative of higher evolutionary divergence in their evolutionary process. This rela-
tionship was studied using the number of protein families sharing more than 35% identity
(S35 number in CATH) and the number of structural cluster in the corresponding structural
Fig 4. Distribution of number of GO terms associated with folds with more and less than 5 biopeptides. Distributions
of different GO terms per each class (Molecular function, Cellular components and Biological process) for proteins showing
less than 5 and 5 or more BP (panels a, b, and c). Panel d, shows the same distribution but now using FunTree clusters
information. In all the cases it is possible to observe that proteins with more than 5 BPs are functionally more diverse than
those proteins with less than 5 BPs.
https://doi.org/10.1371/journal.pone.0191063.g004
Mapping bioactive peptides in proteins fold
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superfamily. It is interesting to note, that only two protein families corresponding with 5 or
more biopeptides mapped have just only one structural cluster (families 3.40.50.720 and
2.60.40.10 see Fig 5) but with a large number of associated S35. These families correspond to a
Rossman-like and the Inmunoglobulin domains respectively. As we mentioned above, these
domains are called “supefolds” [30] because they are very well conserved from the structural
point of view but are extremely diverse in the sequence and functional dimension.
Mapped biopeptides and putative hot-spots of protein structural
superfamilies
Using structural superfamilies with 5 or more biopeptides mapped in the corresponding repre-
sentative fold we found that the different biopeptides, also those with different biological func-
tions, overlap in certain regions of the structure. For example, in Fig 6, we represent 7 different
BP activity classes indicated with different colours (ACE inhibitor, antibacterial, antioxidative,
chemotactic, inmunomodulating, neuropeptide and stimulating) mapped onto the representa-
tive fold. It is possible to see that different BPs are mapped in similar regions of the protein
fold. Similar results are found in different protein families (S1 and S2 Figs). These figures cor-
responds to well populated folds with several BP mapped (different colours indicate different
biological activity (as indicated also in Table 2). When we explored general characters of these
regions, we were unable to find any correlation between occurrence of biopeptides in the sur-
face or buried areas of mapped proteins, neither a correlation with the type of biopeptide’s bio-
logical activity. It is then possible that BPs at the superfamily level occur in some “hot-spots”
regions.
Conclusions
Taking into account that all proteins may be considered to contain BP [32,33] we studied
BPs distribution in sequence and protein structural space. We followed the simpler possible
analysis to identify putative BPs in protein sequences using 100% identity matches to well
Fig 5. Number of different structural and sequential clusters derived from CATH database. Blue dots represent proteins
with less than 5 BPs and the orange ones those with 5 or more BPs. It is possible to see that proteins with more than 5 BPs are
more diverse structurally and sequentially.
https://doi.org/10.1371/journal.pone.0191063.g005
Mapping bioactive peptides in proteins fold
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established BPs deposited in BIOPEP database. After our large-scale BP mapping, two major
results emerged from our analysis. The first one is that proteins containing high number of
BPs (5) belong to superfamilies very diverse in their sequences and in their biological func-
tions (Fig 4). Each superfamily is represented by a given protein fold which is conserved
among all the members as an evidence of homology between all their sequences. However, in
those superfamilies with proteins with 5 or more BPs in their sequences these representative
fold shows a higher structural variability (Fig 5). Protein folds associated to a great number of
homologous families with the same or different biological function have been called “super-
folds” as derived from a landmark work by Orengo and collaborators [30,34]. As it was esti-
mated that there is a limited number of protein folds in nature [35] it follows that some of
them could be overrepresented given place to the presence of superfolds. Also, they have been
associated with an differentially increased thermostability [36] and with a lesser representation
in microbial superkingdoms Archea and Bacteria in reference with those of Eukarya [37]. The
second main result is that in these proteins with 5 or more BPs in their sequences, BPs with dif-
ferent activities tend to locate in similar regions (putative hotspots) when are mapped in the
representative fold of the superfamily which they belong to (Fig 6, S1 and S2 Figs).
As we mentioned above, BPs sequences are not expected to evolve under a selective pres-
sure in order to preserve its corresponding BP biological activity. BPs express their activity
when are released by proteolytic cleavage or other types of fragmentation in the digestive tract
[38]. As has been previously suggested, BPs environment, flanking solvent exposition regions
as well the presence of hydrophilic regions, could favour the action of proteinases for BPs
release [39]. Taking into account the results obtained in our work, presence of superfolds and
putative hotspots for those proteins with more than 5 BPs, suggest the presence of common
mechanisms to release the BPs during the digestion. Although structurally diverse as suggested
in Fig 5, superfolds, and folds in general, could conserve hydrophilic/hydrophobic regions in
order to conserve the same fold [40] and then solvent exposed areas are also conserved. The
observation of putative hotspots were different activity BPs co-localize, possibly results from
the conservation of solvent exposed regions and putative targets of proteolytic enzymes.
Fig 6. Structure of dethiobiotin synthase (PDB ID 1byi) represented in cartoon representation showing mapped BPs.
Red indicates ACE inhibitor BP activity (14), blue antibacterial (4), yellow inmunomodulating (3), green antioxidative (3),
magenta neuropeptide (1), light grey chemotactic (1) and dark grey stimulating activities (1) (as derived from BIOPEP
database). It is possible to see that different activities have similar location. BPs found in different proteins of the same
superfamily have been mapped on a representative structure (1byi) accordingly to CATH (see Materials and methods).
https://doi.org/10.1371/journal.pone.0191063.g006
Mapping bioactive peptides in proteins fold
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Analysis of protein fold distribution containing BPs (Fig 3) could certainly reveal bias com-
position of sequences in databases and mostly agree with previous results [41,42]. In fact,
rubisco (CATH id 3.30.70.150), the most abundant protein on earth, has been proposed as a
sustainable source of bioactive peptides, supported by in vitro and in vivo analyzes [43].
Table 2. Detail of the sequence and activity of biopeptides of the first four superfamilies with the highest number of biopeptides. The activity corresponds to the clas-
sification in BIOPEP.
CATH Structures/
domains
Number of
BP
Sequences of each BP Activity
3.40.50.300 215 35 GKKVLQ; DYGLYP; PQEVLP; PQEVLP; KVLILA; RADHPF; LAHKAL; KVLAGM;
GLDIQK; VTSTAV; IKPLNY; FQKVVA; VPQPIP; VIEKYP; KVREGT; VHLPPP;
Ace Inhibitor
LKKISQ Ace Inhibitor/
Antibacterial
RRPYIL; KIPYIL Anti Inflammatory
HLPLPL Antiamnestic
STVATL; ALCSEK Antibacterial
IEAEGE; LLPHHH; QYDQGV; GALAAH Antioxidative
LGTIPG; VGVAPG Chemotactic
SIKVAV Immunomodulating/
Anticancer
VGGIPY Immunomodulating
FFGLMG; KRQHPG Neuropeptide
YLGYLE; RYLGYL; GGFLTRH Opioid
SFLLRN Stimulating
3.40.50.720 309 25 VTSTAV; PANIKWGD; PSKIKWGD; QSLVYP; PQEVLP; PANLPWGSSNV; VLAQYK;
VIEKYP; LAHKAL; EPKAIP; KVLAGM; GLDIQK
Ace Inhibitor
LKKISQ Ace Inhibitor/
Antibacterial
ALCSEK Antibacterial
GALAAH; LGFEYY; PKAVHE; ISELGW Antioxidative
RGDSPA Antithrombotic
VGVAPG; LGTIPG; PGAIPG Chemotactic
LVCYPQ Immunomodulating
SIKVAV Immunomodulating/
Anticancer
EVQKQLQ Neuropeptide
3.20.20.70 35 18 KVLILA; VLPYPV; PQEVLP; GKKVLQ; LAHKAL; KVLPVP; YLYEIA; VTSTAV Ace Inhibitor
LKKISQ Ace Inhibitor/
Antibacterial
STVATL Antibacterial
YFYPEL; GALAAH; PKAVHE; EELDNALN; YGYTGA Antioxidative
PGAIPG; VGVAPG Chemotactic
SIKVAV Immunomodulating/
Anticancer
2.60.120.10 246 17 KVLILA; NWGPLV; YLAGNQ; YQEPVL Ace Inhibitor
LSPFWNINA Antiamnestic
STVATL Antibacterial
AIRQGDVF; KHNRGDEF; LLPHHADADY; LVNPHDHQN; VIPAGYP; VLEANPRSF;
YFPVGGDRPESF
Antioxidative
RGDSPA Antithrombotic
HCQRPR Immunomodulating
EITPEKNPQLR; VAWWMY Inhibitor
https://doi.org/10.1371/journal.pone.0191063.t002
Mapping bioactive peptides in proteins fold
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One of the most common procedure to predict the presence of BPs in proteins is the use of
sequence similarity searches using well curated databases [21] followed by in vitro hydrolysis
and/or simulated digestion and identification [44]. Our results also indicate two features that
could improve target-directed search of BPs in proteins. Identification of the fold in which a
given sequence would possible fold, is nowadays routinely used in widely used homology
modeling techniques [45,46]. Fold assignment techniques have also been developed to be used
at the proteomic level [47]. Identification of superfamilies containing superfolds could increase
the detection rate of BPs in wet-screening procedures. Additionally, these detected superfolds
could also contain more than one type of BPs having different biological activities as derived
from our results.
Although it is difficult to put our results in an evolutionary context, just because BPs are
not independent of the evolutionary constraints of the whole protein they belong to, our
results could help in the design of new bioinformatics pipelines to improve predictions of BPs
occurrences.
Supporting information
S1 Fig. Structure of dethiobiotin synthase (PDB ID 1c0p, domain A01 accordingly with
CATH (1c0pA01)) represented in cartoon representation showing mapped BPs. Red indi-
cates ACE inhibitor BP activity (12), green antibacterial(1), blue antioxidative (5) and orange
chemostatic activities (13) (as derived from Biopep database). It is possible to see that different
activities have similar location. BPs found in different proteins of the same superfamily have
been mapped on a representative structure (1c0p) accordingly to CATH.
(TIF)
S2 Fig. Structure of Triosephosphate Isomerase (PDB ID 2vxn, domain A00 accordingly
with CATH (2vxnA00)) represented in cartoon representation showing mapped BPs. Red
indicates ACE inhibitor BP activity (6), green antibacterial (1), blue antioxidative (2) and
orange chemostatic activities (1) (as derived from Biopep database). It is possible to see that
different activities have similar location. BPs found in different proteins of the same superfam-
ily have been mapped on a representative structure (12vxn) accordingly to CATH.
(TIF)
S1 Table. List of complete CATH domains found in the assignation of structure of the
sequences with at least one peptide.
(PDF)
S2 Table. Number of biopeptides and proteins associated with a given protein fold (CATH
id).
(PDF)
Author Contributions
Conceptualization: Gustavo Parisi.
Investigation: Agustina E. Nardo.
Supervision: M. Cristina Año´n, Gustavo Parisi.
Writing – original draft: Agustina E. Nardo.
Writing – review & editing: M. Cristina Año´n, Gustavo Parisi.
Mapping bioactive peptides in proteins fold
PLOS ONE | https://doi.org/10.1371/journal.pone.0191063 January 19, 2018 11 / 14
References
1. Yoshikawa M. Bioactive peptides derived from natural proteins with respect to diversity of their recep-
tors and physiological effects. Peptides. 2015; 72: 208–225. https://doi.org/10.1016/j.peptides.2015.07.
013 PMID: 26297549
2. Zioudrou C, Streaty RA, Klee WA. Opioid peptides derived from food proteins. The exorphins. J Biol
Chem. 1979; 254: 2446–2449. PMID: 372181
3. Udenigwe CC, Aluko RE. Food protein-derived bioactive peptides: production, processing, and poten-
tial health benefits. J Food Sci. 2012; 77: R11–24. https://doi.org/10.1111/j.1750-3841.2011.02455.x
PMID: 22260122
4. de Castro RJS, Sato HH. Biologically active peptides: Processes for their generation, purification and
identification and applications as natural additives in the food and pharmaceutical industries. Food Res
Int. 2015; 74: 185–198. https://doi.org/10.1016/j.foodres.2015.05.013 PMID: 28411983
5. Miner-Williams WM, Stevens BR, Moughan PJ. Are intact peptides absorbed from the healthy gut in the
adult human? Nutr Res Rev. 2014; 27: 308–329. https://doi.org/10.1017/S0954422414000225 PMID:
25623084
6. Daniel H. Molecular and Integrative Physiology of Intestinal Peptide Transport. Annu Rev Physiol.
2004; 66: 361–384. https://doi.org/10.1146/annurev.physiol.66.032102.144149 PMID: 14977407
7. Bougle´ D, Bouhallab S. Dietary bioactive peptides: Human studies. Crit Rev Food Sci Nutr. 2017; 57:
335–343. https://doi.org/10.1080/10408398.2013.873766 PMID: 26067872
8. Wang W, de Mejia EG. A New Frontier in Soy Bioactive Peptides that May Prevent Age-related Chronic
Diseases. Compr Rev Food Sci Food Saf. 2005; 4: 63–78.
9. Mo¨ller NP, Scholz-Ahrens KE, Roos N, Schrezenmeir J. Bioactive peptides and proteins from foods:
indication for health effects. Eur J Nutr. 2008; 47: 171–182. https://doi.org/10.1007/s00394-008-0710-2
PMID: 18506385
10. Cicero AFG, Fogacci F, Colletti A. Potential role of bioactive peptides in prevention and treatment of
chronic diseases: a narrative review. Br J Pharmacol. 2016; https://doi.org/10.1111/bph.13608 PMID:
27572703
11. Li Y-W, Li B, He J, Qian P. Quantitative structure–activity relationship study of antioxidative peptide by
using different sets of amino acids descriptors. J Mol Struct. 2011; 998: 53–61.
12. Pownall TL, Udenigwe CC, Aluko RE. Effects of cationic property on the in vitro antioxidant activities of
pea protein hydrolysate fractions. Food Res Int. 2011; 44: 1069–1074.
13. Pak VV, Koo M, Kwon DY, Yun L. Design of a highly potent inhibitory peptide acting as a competitive
inhibitor of HMG-CoA reductase. Amino Acids. 2012; 43: 2015–2025. https://doi.org/10.1007/s00726-
012-1276-0 PMID: 22451276
14. He R, Aluko RE, Ju X-R. Evaluating molecular mechanism of hypotensive peptides interactions with
renin and angiotensin converting enzyme. PLoS One. 2014; 9: e91051. https://doi.org/10.1371/journal.
pone.0091051 PMID: 24603692
15. Meisel H. Multifunctional peptides encrypted in milk proteins. Biofactors. 2004; 21: 55–61. PMID:
15630170
16. Korhonen H, Pihlanto A. Bioactive peptides: Production and functionality. Int Dairy J. 2006; 16: 945–
960.
17. Shahidi F, Zhong Y. Bioactive peptides. J AOAC Int. 2008; 91: 914–931. PMID: 18727554
18. Martirosyan DM, Singh J. A new definition of functional food by FFC: what makes a new definition
unique? Functional Foods in Health and Disease. 2015; 6: 209–223.
19. Shtatland T, Guettler D, Kossodo M, Pivovarov M, Weissleder R. PepBank–a database of peptides
based on sequence text mining and public peptide data sources. BMC Bioinformatics. 2007; 8: 280.
https://doi.org/10.1186/1471-2105-8-280 PMID: 17678535
20. Wang G, Li X, Wang Z. APD3: the antimicrobial peptide database as a tool for research and education.
Nucleic Acids Res. 2016; 44: D1087–93. https://doi.org/10.1093/nar/gkv1278 PMID: 26602694
21. Minkiewicz P, Dziuba J, Iwaniak A, Dziuba M, Darewicz M. BIOPEP database and other programs for
processing bioactive peptide sequences. J AOAC Int. 2008; 91: 965–980. PMID: 18727559
22. Altschul SF, Madden TL, Schaffer AA, Zhang J, Zhang Z, Miller W, et al. Gapped BLAST and PSI-
BLAST: a new generation of protein database search programs. Nucleic Acids Res. 1997; 25: 3389–
3402. PMID: 9254694
23. Mooney C, Haslam NJ, Holton TA, Pollastri G, Shields DC. PeptideLocator: prediction of bioactive pep-
tides in protein sequences. Bioinformatics. 2013; 29: 1120–1126. https://doi.org/10.1093/
bioinformatics/btt103 PMID: 23505299
Mapping bioactive peptides in proteins fold
PLOS ONE | https://doi.org/10.1371/journal.pone.0191063 January 19, 2018 12 / 14
24. Dave LA, Montoya CA, Rutherfurd SM, Moughan PJ. Gastrointestinal Endogenous Proteins as a
Source of Bioactive Peptides—An In Silico Study. PLoS One. 2014; 9: e98922. https://doi.org/10.1371/
journal.pone.0098922 PMID: 24901416
25. Reeves GA, Dallman TJ, Redfern OC, Akpor A, Orengo CA. Structural diversity of domain superfamilies
in the CATH database. J Mol Biol. 2006; 360: 725–741. https://doi.org/10.1016/j.jmb.2006.05.035
PMID: 16780872
26. Huang Y, Niu B, Gao Y, Fu L, Li W. CD-HIT Suite: a web server for clustering and comparing biological
sequences. Bioinformatics. 2010; 26: 680–682. https://doi.org/10.1093/bioinformatics/btq003 PMID:
20053844
27. Orengo CA, Pearl FMG, Thornton JM. The CATH domain structure database. Methods Biochem Anal.
2003; 44: 249–271. PMID: 12647390
28. Furnham N, Sillitoe I, Holliday GL, Cuff AL, Rahman S a., Laskowski R a., et al. FunTree: A resource for
exploring the functional evolution of structurally defined enzyme superfamilies. Nucleic Acids Res.
2012; 40: 776–782.
29. Higgins DG, Bleasby AJ, Fuchs R. CLUSTAL V: improved software for multiple sequence alignment.
Comput Appl Biosci. 1992; 8: 189–191. PMID: 1591615
30. Orengo CA, Jones DT, Thornton JM. Protein superfamilies and domain superfolds. Nature. 1994; 372:
631–634. https://doi.org/10.1038/372631a0 PMID: 7990952
31. Ashburner M, Ball CA, Blake JA, Botstein D, Butler H, Cherry JM, et al. Gene ontology: tool for the unifi-
cation of biology. The Gene Ontology Consortium. Nat Genet. 2000; 25: 25–29. https://doi.org/10.1038/
75556 PMID: 10802651
32. Karelin AA, Blishchenko EY, Ivanov VT. A novel system of peptidergic regulation. FEBS Lett. 1998;
428: 7–12. PMID: 9645464
33. Dziuba J, Minkiewicz P, Nałecz D, Iwaniak A. Database of biologically active peptide sequences. Nah-
rung. 1999; 43: 190–195. https://doi.org/10.1002/(SICI)1521-3803(19990601)43:3<190::AID-
FOOD190>3.0.CO;2-A PMID: 10399353
34. Orengo C a., Pearl FM, Bray JE, Todd a. E, Martin a. C, Lo Conte L, et al. The CATH Database provides
insights into protein structure/function relationships. Nucleic Acids Res. 1999; 27: 275–279. PMID:
9847200
35. Wolf YI, Grishin NV, Koonin EV. Estimating the number of protein folds and families from complete
genome data. J Mol Biol. 2000; 299: 897–905. https://doi.org/10.1006/jmbi.2000.3786 PMID:
10843846
36. Magner A, Szpankowski W, Kihara D. On the origin of protein superfamilies and superfolds. Sci Rep.
2015; 5: 8166. https://doi.org/10.1038/srep08166 PMID: 25703447
37. Caetano-Anolle´s G, Wang M, Caetano-Anolle´s D, Mittenthal JE. The origin, evolution and structure of
the protein world. Biochem J. 2009; 417: 621–637. https://doi.org/10.1042/BJ20082063 PMID:
19133840
38. Arroume N, Froidevaux R, Kapel R, Cudennec B, Ravallec R, Flahaut C, et al. Food peptides: purifica-
tion, identification and role in the metabolism. Curr Opin Food Sci. 2016; 7: 101–107.
39. Dziuba J, Niklewicz M, Iwaniak A, Minkiewicz MD, Arewicz P. Bioinformatic-aided prediction for release
possibilities of bioactive peptides from plant proteins. Acta Alimentaria. 2004; 33: 227–235.
40. Ladunga I, Smith RF. Amino acid substitutions preserve protein folding by conserving steric and hydro-
phobicity properties. Protein Eng. 1997; 10: 187–196. PMID: 9153083
41. Iwaniak A, Dziuba J. Analysis of Domains in Selected Plant and Animal Food Proteins—Precursors of
Biologically Active Peptides—In Silico Approach. Food Sci Technol Int. 2009; 15: 179–191.
42. Udenigwe CC, Gong M, Wu S. In silico analysis of the large and small subunits of cereal RuBisCO as
precursors of cryptic bioactive peptides. Process Biochem. 2013; 48: 1794–1799.
43. Udenigwe CC, Okolie CL, Qian H, Ohanenye IC, Agyei D, Aluko RE. Ribulose-1,5-bisphosphate car-
boxylase as a sustainable and promising plant source of bioactive peptides for food applications. Trends
Food Sci Technol. 2017; 69: 74–82.
44. Minkiewicz P, Darewicz M, Iwaniak A, Sokołowska J, Starowicz P, Bucholska J, et al. Common Amino
Acid Subsequences in a Universal Proteome—Relevance for Food Science. Int J Mol Sci. 2015; 16:
20748–20773. https://doi.org/10.3390/ijms160920748 PMID: 26340620
45. Soding J, Remmert M, Biegert A, Lupas AN. HHsenser: exhaustive transitive profile search using
HMM-HMM comparison. Nucleic Acids Res. 2006; 34: W374–8. https://doi.org/10.1093/nar/gkl195
PMID: 16845029
Mapping bioactive peptides in proteins fold
PLOS ONE | https://doi.org/10.1371/journal.pone.0191063 January 19, 2018 13 / 14
46. Jaroszewski L, Rychlewski L, Li Z, Li W, Godzik A, Program B, et al. FFAS03: a server for profile–profile
sequence alignments. Genomics. 2005; 33: 284–288.
47. Drew K, Winters P, Butterfoss GL, Berstis V, Uplinger K, Armstrong J, et al. The Proteome Folding Proj-
ect: Proteome-scale prediction of structure and function. Genome Res. 2011; 21: 1981–1994. https://
doi.org/10.1101/gr.121475.111 PMID: 21824995
Mapping bioactive peptides in proteins fold
PLOS ONE | https://doi.org/10.1371/journal.pone.0191063 January 19, 2018 14 / 14
